Most bought healthcare stocks in Q1 2022
See which Healthcare stocks institutional investors increased the most in Q1 2022, measured as net growth in reported share positions from Q4 2021 into Q1 2022. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), AMYLYX PHARMACEUTICALS INC (AMLX), GILEAD SCIENCES INC (GILD), ALIGNMENT HEALTHCARE INC (ALHC). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ELAN | ELANCO ANIMAL HEALTH INC | 7,457,997 | $134.68K | 0 | 2 | 2 | 0 | 4 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 7,316,936 | $94.02K | 2 | 0 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 6,655,915 | -$391.83K | 0 | 6 | 1 | 1 | 7 |
| ALHC | ALIGNMENT HEALTHCARE INC | 5,576,902 | $61.34K | 0 | 1 | 1 | 0 | 2 |
| MRK | MERCK & CO. INC. | 5,298,729 | $57.39M | 1 | 5 | 5 | 0 | 14 |
| WRBY | WARBY PARKER INC-CLASS A | 3,850,231 | -$41.93K | 1 | 2 | 1 | 1 | 4 |
| PFE | PFIZER INC | 3,781,597 | -$6.11M | 1 | 3 | 6 | 0 | 12 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 3,394,576 | $127.12K | 1 | 2 | 0 | 0 | 3 |
| MRNA | MODERNA INC | 2,682,307 | $306.88K | 1 | 3 | 0 | 1 | 4 |
| MCK | MCKESSON CORP | 2,627,169 | $980.66K | 1 | 2 | 1 | 1 | 4 |
| EHC | ENCOMPASS HEALTH CORP | 2,550,430 | $187.45K | 0 | 3 | 0 | 0 | 3 |
| OSCR | OSCAR HEALTH INC - CLASS A | 2,522,090 | $51.62K | 0 | 2 | 1 | 0 | 4 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 2,467,398 | -$471.86K | 1 | 1 | 0 | 0 | 3 |
| ABCL | ABCELLERA BIOLOGICS INC | 2,078,400 | $17.81K | 0 | 1 | 0 | 0 | 1 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 2,020,119 | $67.25K | 0 | 3 | 1 | 0 | 5 |
| ME | 23ANDME HOLDING CO -CLASS A | 1,988,869 | $7.34K | 2 | 0 | 1 | 0 | 3 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,953,371 | -$290.80K | 0 | 2 | 0 | 0 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 1,939,179 | $1.40M | 0 | 3 | 3 | 0 | 6 |
| IONS | IONIS PHARMACEUTICALS INC | 1,917,254 | $119.36K | 1 | 0 | 2 | 0 | 3 |
| NUVB | NUVATION BIO INC | 1,863,073 | -$30.42K | 0 | 2 | 0 | 0 | 4 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,764,815 | $861.17K | 3 | 4 | 2 | 0 | 12 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 1,745,118 | -$283.83K | 1 | 1 | 0 | 0 | 2 |
| HOLX | HOLOGIC INC | 1,686,010 | $96.68K | 1 | 2 | 1 | 0 | 5 |
| XRAY | DENTSPLY SIRONA INC | 1,589,184 | $17.50K | 0 | 3 | 0 | 0 | 3 |
| VTRS | VIATRIS INC | 1,566,346 | -$236.47K | 0 | 2 | 1 | 0 | 3 |
| TWST | TWIST BIOSCIENCE CORP | 1,497,052 | -$31.59K | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,398,071 | -$609.21K | 0 | 1 | 4 | 0 | 8 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | 1,318,170 | $38.93K | 1 | 1 | 0 | 0 | 2 |
| AUPH | AURINIA PHARMACEUTICALS INC | 1,227,129 | $10.29K | 0 | 1 | 0 | 0 | 1 |
| INCY | INCYTE CORP | 1,123,493 | $227.09K | 0 | 2 | 2 | 0 | 4 |
| CLDX | CELLDEX THERAPEUTICS INC | 1,088,766 | $33.61K | 0 | 1 | 0 | 0 | 1 |
| PGEN | PRECIGEN INC | 1,072,156 | -$8.15K | 0 | 1 | 1 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 1,034,415 | $26.59K | 0 | 3 | 3 | 0 | 6 |
| A | AGILENT TECHNOLOGIES INC | 1,025,141 | -$38.52K | 0 | 4 | 0 | 1 | 5 |
| IVVD | INVIVYD INC | 987,114 | $4.50K | 1 | 0 | 0 | 0 | 1 |
| ALLO | ALLOGENE THERAPEUTICS INC | 974,700 | $8.88K | 1 | 0 | 0 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | 959,489 | -$10.13K | 1 | 0 | 1 | 0 | 2 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 954,800 | $3.39K | 1 | 0 | 0 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | 940,000 | $4.56K | 1 | 0 | 0 | 0 | 1 |
| ATOS | ATOSSA THERAPEUTICS INC | 930,152 | $753 | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 922,604 | -$166.06K | 1 | 2 | 1 | 1 | 5 |
| BAX | BAXTER INTERNATIONAL INC | 883,527 | $58.22K | 0 | 2 | 2 | 0 | 6 |
| EXAS | EXACT SCIENCES CORP | 827,948 | -$48.86K | 0 | 1 | 0 | 0 | 1 |
| SANA | SANA BIOTECHNOLOGY INC | 783,400 | $6.06K | 0 | 1 | 0 | 0 | 1 |
| RXRX | RECURSION PHARMACEUTICALS-A | 773,550 | -$16.71K | 1 | 1 | 0 | 0 | 2 |
| CVM | CEL-SCI CORP | 772,883 | $3.04K | 1 | 0 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 770,472 | -$143.43K | 0 | 2 | 0 | 0 | 3 |
| GH | GUARDANT HEALTH INC | 737,763 | -$122.55K | 0 | 1 | 0 | 1 | 1 |
| IQV | IQVIA HOLDINGS INC | 734,063 | $35.52K | 1 | 1 | 2 | 0 | 4 |
| VKTX | VIKING THERAPEUTICS INC | 724,476 | $1.78K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2022
What are the most bought Healthcare stocks in Q1 2022?
The most bought healthcare stocks in Q1 2022 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2022?
Among the managers we track, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), AMYLYX PHARMACEUTICALS INC (AMLX), GILEAD SCIENCES INC (GILD), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2021).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.